{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:12:07Z","timestamp":1791634327529,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010897","name":"Newton Fund","doi-asserted-by":"publisher","award":["ITD-ITCZRU56"],"award-info":[{"award-number":["ITD-ITCZRU56"]}],"id":[{"id":"10.13039\/100010897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","award":["MISP 60147"],"award-info":[{"award-number":["MISP 60147"]}],"id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"UK Government Foreign Commonwealth &amp; Development Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"United Kingdom Department of Health &amp; Social Care","doi-asserted-by":"publisher","award":["MR\/T005076\/1"],"award-info":[{"award-number":["MR\/T005076\/1"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016270","name":"Global Challenges Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.128002","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:42:26Z","timestamp":1764261746000},"page":"128002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Knowledge and acceptability of male HPV vaccination among young people and community stakeholders in northwest Tanzania: social sciences in the Add-Vacc trial"],"prefix":"10.1016","volume":"69","author":[{"given":"Susan A.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Changalucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donati","family":"Malibwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Mkungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick","family":"Deogratias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadhan","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi","family":"Kapiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Baisley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Watson-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128002_bb0005","series-title":"Human Papillomavirus and Related Diseases Report in United Republic of Tanzania","author":"Bruni","year":"2021"},{"key":"10.1016\/j.vaccine.2025.128002_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128002_bb0015","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2025.128002_bb0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/sextrans-2013-051456","article-title":"Human papillomavirus prevalence among men in sub-Saharan Africa: a systematic review and meta-analysis","volume":"90","author":"Olesen","year":"2014","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2025.128002_bb0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/OLQ.0b013e31828fcf57","article-title":"Prevalence and type distribution of human papillomavirus among 1813 men in Tanzania and the relationship to HIV status","volume":"40","author":"Olesen","year":"2013","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2025.128002_bb0030","first-page":"51","article-title":"Prevalence and concordance of penile, anal, and oral human papillomavirus infections among sexually active heterosexual men in Ibadan","volume":"1","author":"Morhason-Bello","year":"2025","journal-title":"Nigeria Cancer Causes Control"},{"key":"10.1016\/j.vaccine.2025.128002_bb0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2025.128002_bb0040","unstructured":"Merck & Co. Inc. Gardasil Package Insert. Package Insert 2011. https:\/\/www.fda.gov\/files\/vaccines, blood & biologics\/published\/Package-Insert---Gardasil.pdf [accessed May 23, 2022]."},{"key":"10.1016\/j.vaccine.2025.128002_bb0045","first-page":"630","article-title":"FDA licensure of Quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the advisory committee on immunization practices (ACIP)","volume":"59","author":"U.S. Centers for Disease Control and Prevention (CDC).","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.128002_bb0050","unstructured":"World Health Organization (WHO). WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer 2018. http:\/\/www.who.int\/reproductivehealth\/call-to-action-elimination-cervical-cancer\/en\/ (accessed March 23, 2022)."},{"key":"10.1016\/j.vaccine.2025.128002_bb0055","unstructured":"World Health Organization (WHO) HPV dashboard. Website 2025. https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases\/human-papillomavirus-vaccines-(HPV)\/hpv-clearing-house\/hpv-dashboard [accessed May 1, 2025]."},{"key":"10.1016\/j.vaccine.2025.128002_bb0060","unstructured":"World Health Organization (WHO). Report on global sexually transmitted infection surveillance 2018 2018. https:\/\/www.who.int\/reproductivehealth\/publications\/stis-surveillance-2018\/en\/ (accessed March 22, 2022)."},{"key":"10.1016\/j.vaccine.2025.128002_bb0065","unstructured":"GAVI: The Vaccine Alliance. Tanzania \u2013 Key vaccination indicators April 2025 n.d. https:\/\/www.gavi.org\/programmes-impact\/country-hub\/africa\/tanzania-ur (accessed May 2, 2025)."},{"key":"10.1016\/j.vaccine.2025.128002_bb0070","first-page":"7","article-title":"Commentary on COVID-19 vaccine hesitancy in sub-Saharan Africa","author":"Kabakama","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128002_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18357\/anthropologica66120242646","article-title":"Political and community logics of emergent Disease vaccine deployment: anthropological Insights from DRC, Uganda and Tanzania","volume":"66","author":"Lees","year":"2024","journal-title":"Anthropologica"},{"key":"10.1016\/j.vaccine.2025.128002_bb0080","unstructured":"World Health Organization (WHO). COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades 2022. https:\/\/www.who.int\/news\/item\/15-07-2022-covid-19-pandemic-fuels-largest-continued-backslide-in-vaccinations-in-three-decades (accessed January 31, 2025)."},{"key":"10.1016\/j.vaccine.2025.128002_bb0085","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/j.vaccine.2021.04.025","article-title":"National introduction of human papillomavirus (HPV) vaccine in Tanzania: programmatic decision-making and implementation","volume":"40","author":"Mphuru","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128002_bb0090","first-page":"545","article-title":"The use of triangulation in qualitative research","volume":"41","author":"Carter","year":"2014","journal-title":"Oncol Nurs Soc"},{"key":"10.1016\/j.vaccine.2025.128002_bb0095","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.vaccine.2012.06.025","article-title":"A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in Northwest Tanzania","volume":"30","author":"Remes","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128002_bb0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1037\/0003-066X.32.7.513","article-title":"Toward an experimental ecology of human development","author":"Bronfenbrenner","year":"1977","journal-title":"Am Psychol"},{"key":"10.1016\/j.vaccine.2025.128002_bb0105","series-title":"Readings on the development of children","first-page":"37","article-title":"Ecological models of human development","author":"Bronfenbrenner","year":"1993"},{"key":"10.1016\/j.vaccine.2025.128002_bb0110","unstructured":"Awami S. Tanzania president raises doubts over COVID vaccines. Aljazeera News (Online) 27 Jan 2021. aljazeera.com\/news\/2021\/1\/27\/tanzania-president-denounces-covid-vaccines (accessed November 16 2025)."},{"key":"10.1016\/j.vaccine.2025.128002_bb0115","unstructured":"Kombe C. Tanzania\u2019s president criticized for dismissing COVID-19 vaccines. Voice of America News (Online) 28 January 2021. voanews.com\/a\/covid-19-pandemic_tanzania-president-criticized-dismissing-covid-19-vaccines\/6201338.html (accessed November 16, 2025)."},{"key":"10.1016\/j.vaccine.2025.128002_bb0120","first-page":"13","article-title":"Barriers towards HPV Vaccinatons for boys and young men: a narrative review","author":"Grandahl","year":"2021","journal-title":"Viru"},{"key":"10.1016\/j.vaccine.2025.128002_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-016-3517-8","article-title":"Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries","volume":"16","author":"Kabakama","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.128002_bb0130","series-title":"Summary WHO SAGE conclusions and recommendations on Vaccine Hesitancy","author":"MacDonald","year":"2015"},{"key":"10.1016\/j.vaccine.2025.128002_bb0135","unstructured":"Watson-Jones D, Changalucha J, Whitworth H, Pinto L, Mutani P, Indangasi J, et al. Immunogenicity and safety results comparing single dose human papillomavirus vaccine with two or three doses in Tanzanian girls \u2013 the DoRIS randomised trial n.d."},{"key":"10.1016\/j.vaccine.2025.128002_bb0140","first-page":"1","article-title":"Comparison of immune responses after one dose of HPV vaccine in a dose-reduction HPV vaccine trial in adolescent girls in Tanzania to the Costa Rica Vaccine and India HPV vaccine trials","author":"Baisley","year":"2022","journal-title":"Lancet (Preprint)"},{"key":"10.1016\/j.vaccine.2025.128002_bb0145","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.vaccine.2019.12.017","article-title":"Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: a systematic review of evidence from clinical trials","volume":"38","author":"Whitworth","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128002_bb0150","unstructured":"World Health Organization (WHO). One-dose human papillomavirus (HPV) vaccine offers solid protection against cervical cancer. World Health Organization Website 2022. https:\/\/www.who.int\/news\/item\/11-04-2022-one-dose-human-papillomavirus-(hpv)-vaccine-offers-solid-protection-against-cervical-cancer [accessed February 4, 2025]."},{"key":"10.1016\/j.vaccine.2025.128002_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pvr.2018.10.004","article-title":"Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries","volume":"6","author":"Gallagher","year":"2018","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.vaccine.2025.128002_bb0160","unstructured":"World Health Organization (WHO). Over 5 million girls in Tanzania to receive HPV vaccine to combat cervical cancer. World Health Organization Website 2024. https:\/\/www.afro.who.int\/countries\/united-republic-of-tanzania\/news\/over-5-million-girls-tanzania-receive-hpv-vaccine-combat-cervical-cancer [accessed February 3, 2025]."},{"key":"10.1016\/j.vaccine.2025.128002_bb0165","series-title":"Vaccination and trust: How concerns arise and the role of communication in mitigating crises. Copenhagen","author":"World Health Organization (WHO)","year":"2017"},{"key":"10.1016\/j.vaccine.2025.128002_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-016-3799-x","article-title":"Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone","volume":"16","author":"Enria","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.128002_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258252","article-title":"Bringing the social into vaccination research: community health worker-led ethnography and trust-building in immunization programs in Sierra Leone","volume":"16","author":"Enria","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128002_bb0180","first-page":"7","article-title":"Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case Control study","author":"Watson-Jones","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128002_bb0185","doi-asserted-by":"crossref","unstructured":"Enria L, Lees S. Citizens, Dependents, Sons of the soil: defining political subjectivities through encounters with biomedicine during the Ebola epidemic in Sierra Leone. Med Anthropol Theory 2018;5.","DOI":"10.17157\/mat.5.4.512"},{"key":"10.1016\/j.vaccine.2025.128002_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-079940","article-title":"Political dimensions of misinformation, trust, and vaccine confidence in a digital age","author":"Enria","year":"2024","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:33:37Z","timestamp":1778679217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S0264410X25013003"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowledge and acceptability of male HPV vaccination among young people and community stakeholders in northwest Tanzania: social sciences in the Add-Vacc trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128002"}}